NEO
Neogenomics Inc.
Halal Rating :
Last Price
$14.20
Last updated:
Market Cap
-
7D Change
12.43%
1 Year Change
-11.25%
Company Overview
Industries
Exchange
Next Earnings Date
NeoGenomics, Inc. operates a network of cancer-focused genetic testing laboratories in the United States, Europe, and Asia. The company offers testing services to pathologists, oncologists, academic centers, hospital systems, and other clinical laboratories. Their services include cytogenetics testing, molecular testing, flow cytometry testing, and immunohistochemistry testing. These tests are used to diagnose cancer, determine prognosis, and guide treatment decisions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $167.82m | $190.66m | - | $1.64m | 0.00% | 0.86% |
| June 30, 2024 | $164.5m | $188.11m | - | $1.67m | 0.00% | 0.89% |
| March 31, 2024 | $156.24m | $188.49m | - | $1.69m | 0.00% | 0.89% |
Company Impact
Help us evaluate Neogenomics Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.